Molecular biomarkers to predict response to immunotherapy in endometrial cancer patients enrolled on the profile related evidence determining individualized cancer therapy (PREDICT) trial (NCT02478931) at the UC San Diego Moores Cancer Center

Autor: Charo, L.M., Okamura, R., Eskander, R.N., Binder, P.S., Ramkissoon, S., Lee, S., Danziger, N., Kato, S., Saenz, C.C., Plaxe, S.C., Kurzrock, R., Elvin, J.A., McHale, M.T.
Zdroj: In Gynecologic Oncology October 2020 159 Supplement 1:231-232
Databáze: ScienceDirect
Externí odkaz: